Initial Public Offering

Biotech Blogs

Pharma and Biotech IPOs of 2026: A Running List
Biotech News

Clinical-Stage Biotech Kardigan Raises $460 Million in Nasdaq IPO
Biotech News

Parabilis Medicines IPO Supports Cancer Drug Pipeline Targeting “Undruggable” Proteins
Biotech News

Avalyn Pharma IPO Raises $345M for Inhaled Lung Disease Drugs
Biotech News

Hemab Therapeutics IPO Raises $346.7M for Bleeding Disorder Pipeline
Biotech News

Seaport Therapeutics IPO Raises $260M for Neuropsychiatry Pipeline
Biotech News

Odyssey Therapeutics IPO Aims to Address IBD “Therapeutic Ceiling”
Life Science News

Mobia Medical IPO Raises $150M for Stroke Recovery Device
Business & Finance News

Healthcare IPOs in 2026: A Roundup
Business & Finance News

GMR Solutions IPO Brings Ambulance Services to the NYSE
Biotech Blogs

Biotech Funding 2026 Tracker: Latest Raises, Rounds and R&D Momentum
Business & Finance News

MiniMed IPO Points to Smarter Diabetes Devices
Biotech News

Alamar Biosciences IPO Raises $219.9M for Blood-Based Biomarker Tools
Biotech News

Kailera Therapeutics IPO Raises $718.8M for Obesity Drug Pipeline
Biotech News

Eikon Therapeutics IPO Brings in $381M for Oncology Pipeline
Biotech News

Veradermics $294.8M IPO to Fund Phase III Hair Loss Trials